Drug profile: galcanezumab for prevention of cluster headache
| Autor: | Teshamae S. Monteith, Dharani Mudugal |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
medicine.medical_specialty Calcitonin Gene-Related Peptide Drug profile Cluster Headache Calcitonin gene-related peptide Antibodies Monoclonal Humanized 03 medical and health sciences 0302 clinical medicine Double-Blind Method Internal medicine medicine Humans Pharmacology (medical) Severely disabling business.industry General Neuroscience Cluster headache medicine.disease 030227 psychiatry Endocrinology Pharmaceutical Preparations nervous system Calcitonin Neurology (clinical) Trigeminal autonomic cephalalgia business 030217 neurology & neurosurgery |
| Zdroj: | Expert Review of Neurotherapeutics. 21:145-155 |
| ISSN: | 1744-8360 1473-7175 |
| DOI: | 10.1080/14737175.2021.1852931 |
| Popis: | Introduction: Cluster headache [CH] is a severely disabling trigeminal autonomic cephalalgia [TAC]. Approximately 1 in 1,000 adults are affected by CH. Calcitonin gene-related peptide [CGRP] is an ... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|